<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nogr</journal-id><journal-title-group><journal-title xml:lang="ru">Экспериментальная и клиническая гастроэнтерология</journal-title><trans-title-group xml:lang="en"><trans-title>Experimental and Clinical Gastroenterology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-8658</issn><publisher><publisher-name>«Global Media Technologies»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.31146/1682-8658-ecg-211-3-80-88</article-id><article-id custom-type="elpub" pub-id-type="custom">nogr-2339</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОР</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEW</subject></subj-group></article-categories><title-group><article-title>Синдром диспепсии в практике врача первичного звена здравоохранения: клинико-морфологические ассоциации</article-title><trans-title-group xml:lang="en"><trans-title>Dyspepsia syndrome in the practice of a primary care physician: clinical and morphological associations</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6581-7017</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ливзан</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Livzan</surname><given-names>M. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лялюкова</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Lyalyukova</surname><given-names>E. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мозговой</surname><given-names>С. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Mozgovoy</surname><given-names>S. I.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мартиросян</surname><given-names>К. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Martirosyan</surname><given-names>K. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Телятникова</surname><given-names>Л. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Telyatnikova</surname><given-names>L. I.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мигунова</surname><given-names>Ю. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Migunova</surname><given-names>Yu. Yu.</given-names></name></name-alternatives><email xlink:type="simple">migunovajulia@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Омский государственный медицинский университет» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Omsk State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Клинико-диагностический центр «Ультрамед»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>“Ultramed” Clinical and Diagnostic Center</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Майкопский государственный технологический университет»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Maykop State Technological University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>25</day><month>07</month><year>2023</year></pub-date><volume>0</volume><issue>3</issue><fpage>80</fpage><lpage>88</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ливзан М.А., Лялюкова Е.А., Мозговой С.И., Мартиросян К.А., Телятникова Л.И., Мигунова Ю.Ю., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Ливзан М.А., Лялюкова Е.А., Мозговой С.И., Мартиросян К.А., Телятникова Л.И., Мигунова Ю.Ю.</copyright-holder><copyright-holder xml:lang="en">Livzan M.A., Lyalyukova E.A., Mozgovoy S.I., Martirosyan K.A., Telyatnikova L.I., Migunova Y.Y.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.nogr.org/jour/article/view/2339">https://www.nogr.org/jour/article/view/2339</self-uri><abstract><p>Цель исследования: представить морфологическую характеристику изменений слизистой оболочки желудка у пациентов с синдромом диспепсии. Материалы и методы: В исследование включено 262 пациентов, (мужчин - 25,6%, n=67; женщин - 74,4%, n=195), медиана возраста составила 57 (45;64) лет. Изучались результаты лабораторно-инструментальных исследований, клинико-анамнестические данные. Во всех случаях взята биопсия по стандарту из пяти точек (два биоптата из антрального отдела желудка, два биоптата из тела желудка, один - из угла желудка) для верификации степени, стадии гастрита и диагностики H. pylori статуса. Результаты: Исследование показало, что у пациентов в возрасте 57 (45;64) лет с диспепсическими жалобами на этапе первичной медико-санитарной помощи, преобладающим вариантом диспепсии был синдромом эпигастральной боли. У всех пациентов с синдромом диспепсии имелись признаки хронического гастрита. По данным гистобактериоскопии, воспаление III или IV степени чаще регистрировалось у пациентов на фоне H. pylori -позитивного гастрита (78,6% против 30,8% у пациентов с H. pylori - негативным гастритом, р&lt;0,001). У пациентов с H. pylori - негативным гастритом была более выражена стадия атрофии (III или IV стадия регистрировалась у 18,5% пациентов против 7,1% у пациентов с H. рylori негативным гастритом, р&lt;0,001). Для уточнения этиологии гастрита, в случае отрицательного результата гистобактериоскопии на H. рylori, целесообразно подтвердить отсутствие H. рylori вторым методом с использованием дыхательного уреазного теста С 13 или детекции антигена H.pylori в кале или теста на антитела в крови к H. рylori; исключить персистенцию иммунного воспаления вследствие генетической предрасположенности у ранее инфицированных лиц; исключить другие, более редкие этиологические формы гастрита.</p></abstract><trans-abstract xml:lang="en"><p>Aim: to present the morphological characteristics of changes in the gastric mucosa in patients with dyspepsia syndrome. Materials and methods: The study included 262 patients (men - 25.6%, n=67; women - 74.4%, n=195), the median age was 57 (45;64) years. The results of laboratory and instrumental studies, clinical and anamnestic data were studied. In all cases, a biopsy was taken according to the standard of five points (two biopsies from the antrum of the stomach, two biopsies from the stomach body, one from the corner of the stomach) to verify the grade of inflammation, stage of gastritis and diagnosis of H. pylori status. Results: The study showed that in patients aged 57 (45;64) years with dyspeptic complaints at the stage of primary health care, the predominant variant of dyspepsia was epigastric pain syndrome. All patients with dyspepsia syndrome had signs of chronic gastritis. According to histobacterioscopy, grade III or IV inflammation was more often registered in patients with H. pylori-positive gastritis (78.6% vs. 30.8% in patients with H. pylori - negative gastritis, p&lt;0.001). In patients with H. pylori - negative gastritis the stage of atrophy was higher (stage III or IV was registered in 18.5% of patients vs. 7.1% in patients with H. pylori negative gastritis, p&lt;0.001). To clarify the etiology of gastritis, in case of a negative result of histobacterioscopy for H. pylori, it is advisable to confirm the absence of H. pylori by the second method using a respiratory urease test C13 or detection of H.pylori antigen in feces or a test for antibodies in the blood to H. pylori; exclude the persistence of immune inflammation due to genetic predisposition in previously infected persons; exclude other, rarer etiological forms of gastritis.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>Инфекция H. pylori</kwd><kwd>диспепсия</kwd><kwd>хронический гастрит</kwd><kwd>воспаление слизистой оболочки желудка</kwd></kwd-group><kwd-group xml:lang="en"><kwd>H. pylori infection</kwd><kwd>dyspepsia</kwd><kwd>chronic gastritis</kwd><kwd>inflammation of the gastric lining</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Shklyaev A.E., Shutova A. A., Kazarin D. D., Grigoreva O. A., Maksimov K. V. Characteristic of eating behavior in functional dispepsy. Voprosy pitaniia [Problems of Nutrition]. 2022; 91 (4): 74-82. (in Russ.) doi: 10.33029/0042-8833-2022-91-4-74-82.@@ Шкляев А. Е., Шутова А. А., Казарин Д. Д., Григорьева О. А., Максимов К. В. Характеристика пищевого поведения при функциональной диспепсии // Вопросы питания. 2022. Т. 91, № 4. С. 74-82. doi: 10.33029/0042-8833-2022-91-4-74-82.</mixed-citation><mixed-citation xml:lang="en">Shklyaev A.E., Shutova A. A., Kazarin D. D., Grigoreva O. A., Maksimov K. V. Characteristic of eating behavior in functional dispepsy. Voprosy pitaniia [Problems of Nutrition]. 2022; 91 (4): 74-82. (in Russ.) doi: 10.33029/0042-8833-2022-91-4-74-82.@@ Шкляев А. Е., Шутова А. А., Казарин Д. Д., Григорьева О. А., Максимов К. В. Характеристика пищевого поведения при функциональной диспепсии // Вопросы питания. 2022. Т. 91, № 4. С. 74-82. doi: 10.33029/0042-8833-2022-91-4-74-82.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">British Society of Gastroenterology guidelines on the management of functional dyspepsia/Christopher J Black, Peter A Paine, Anurag Agrawal, Imran Aziz, Maria P Eugenicos, Lesley A Houghton, Pali Hungin, Ross Overshott, Dipesh H Vasant, Sheryl Rudd, Richard C Winning, Maura Corsetti, Alexander C Ford// Gut: first published as doi: 10.1136/gutjnl-2022-327737 on 7 July 2022.</mixed-citation><mixed-citation xml:lang="en">British Society of Gastroenterology guidelines on the management of functional dyspepsia/Christopher J Black, Peter A Paine, Anurag Agrawal, Imran Aziz, Maria P Eugenicos, Lesley A Houghton, Pali Hungin, Ross Overshott, Dipesh H Vasant, Sheryl Rudd, Richard C Winning, Maura Corsetti, Alexander C Ford// Gut: first published as doi: 10.1136/gutjnl-2022-327737 on 7 July 2022.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Chung SH, Lee KJ, Kim JY, Im SG, Kim E, Yang MJ, Ryu SH. Association of the Extent of Atrophic Gastritis With Specific Dyspeptic Symptoms. J Neurogastroenterol Motil. 2015 Oct 1;21(4):528-36. doi: 10.5056/jnm15074.</mixed-citation><mixed-citation xml:lang="en">Chung SH, Lee KJ, Kim JY, Im SG, Kim E, Yang MJ, Ryu SH. Association of the Extent of Atrophic Gastritis With Specific Dyspeptic Symptoms. J Neurogastroenterol Motil. 2015 Oct 1;21(4):528-36. doi: 10.5056/jnm15074.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Jones R. Primary care research and clinical practice: gastroenterology. Postgrad Med J 2008; 84:454-8. doi:10.1136/pgmj.2008.068361.</mixed-citation><mixed-citation xml:lang="en">Jones R. Primary care research and clinical practice: gastroenterology. Postgrad Med J 2008; 84:454-8. doi:10.1136/pgmj.2008.068361.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Sperber AD, Bangdiwala SI, Drossman. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation global study. Gastroenterology. 2021;160:99-114. doi: 10.1053/j.gastro.2020.04.014.</mixed-citation><mixed-citation xml:lang="en">Sperber AD, Bangdiwala SI, Drossman. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation global study. Gastroenterology. 2021;160:99-114. doi: 10.1053/j.gastro.2020.04.014.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Rahman MM, Ghoshal UC, Kibria MG, et al. Functional dyspepsia, peptic ulcer, and Helicobacter pylori infection in a rural community of South Asia: An endoscopy-assisted household survey. Clin Transl Gastroenterol. 2021;12: e00334. doi:10.14309/ctg.</mixed-citation><mixed-citation xml:lang="en">Rahman MM, Ghoshal UC, Kibria MG, et al. Functional dyspepsia, peptic ulcer, and Helicobacter pylori infection in a rural community of South Asia: An endoscopy-assisted household survey. Clin Transl Gastroenterol. 2021;12: e00334. doi:10.14309/ctg.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Sperber AD, Bangdiwala SI, Drossman. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation global study. Gastroenterology. 2021;160:99-114. doi: 10.1053/j.gastro.2020.04.014.</mixed-citation><mixed-citation xml:lang="en">Sperber AD, Bangdiwala SI, Drossman. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation global study. Gastroenterology. 2021;160:99-114. doi: 10.1053/j.gastro.2020.04.014.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Goh KL, Chan WK, Shiota S, Yamaoka Y. Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter. 2011;16:1-9. doi: 10.1111/j.1523-5378.2011.00874.x.</mixed-citation><mixed-citation xml:lang="en">Goh KL, Chan WK, Shiota S, Yamaoka Y. Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter. 2011;16:1-9. doi: 10.1111/j.1523-5378.2011.00874.x.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Ford AC, Marwaha A, Lim A, Moayyedi P. What is the prevalence of clinically significant endoscopic findings in subjects with dyspepsia? Systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2010;8(10):830-837. doi:10.1016/j.cgh.2010.05.031.</mixed-citation><mixed-citation xml:lang="en">Ford AC, Marwaha A, Lim A, Moayyedi P. What is the prevalence of clinically significant endoscopic findings in subjects with dyspepsia? Systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2010;8(10):830-837. doi:10.1016/j.cgh.2010.05.031.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Faintuch JJ, Silva FM, Navarro-Rodriguez T, et al. Endoscopic findings in uninvestigated dyspepsia. BMC Gastroenterol. 2014;14:19. doi:10.1186/1471-230X-14-19.</mixed-citation><mixed-citation xml:lang="en">Faintuch JJ, Silva FM, Navarro-Rodriguez T, et al. Endoscopic findings in uninvestigated dyspepsia. BMC Gastroenterol. 2014;14:19. doi:10.1186/1471-230X-14-19.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Peura DA, Haber MM, Hunt B, Atkinson S. Helicobacter pylori-negative gastritis in erosive esophagitis, nonerosive reflux disease or functional dyspepsia patients. J Clin Gastroenterol. 2010;44:3. doi:10.1097/MCG.0b013e3181ac9830.</mixed-citation><mixed-citation xml:lang="en">Peura DA, Haber MM, Hunt B, Atkinson S. Helicobacter pylori-negative gastritis in erosive esophagitis, nonerosive reflux disease or functional dyspepsia patients. J Clin Gastroenterol. 2010;44:3. doi:10.1097/MCG.0b013e3181ac9830.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Aruin L. I., Kononov A. V., Mozgovoy S. I.International classification of chronic gastritis: what should be accepted and what is in doubt. Arch. Pat. 2009;(4):11-18. (in Russ.) EDN: KWQQOL.@@ Аруин Л. И., Кононов А. В., Мозговой С. И. Международная классификация хронического гастрита: что следует принять и что вызывает сомнения // Арх. пат. - 2009. - Вып. 4. - С. 11-18. EDN: KWQQOL.</mixed-citation><mixed-citation xml:lang="en">Aruin L. I., Kononov A. V., Mozgovoy S. I.International classification of chronic gastritis: what should be accepted and what is in doubt. Arch. Pat. 2009;(4):11-18. (in Russ.) EDN: KWQQOL.@@ Аруин Л. И., Кононов А. В., Мозговой С. И. Международная классификация хронического гастрита: что следует принять и что вызывает сомнения // Арх. пат. - 2009. - Вып. 4. - С. 11-18. EDN: KWQQOL.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kardasheva S. S., Kartavenko I. M., Maksimova N. B., Yurieva E. Yu., Popova I. R., Pavlov C. S., Ivashkin V. T. Efficacy of Trimebutine Maleate (Trimedat®) in the Treatment of Patients with Functional Dyspepsia: Results of the “TREND” Observational Study.Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2018;28(5):67-76. (In Russ.) doi: 10.22416/1382-4376-2018-28-5-67-76.@@ Кардашева С. С., Картавенко И. М., Максимова Н. Б., Юрьева Е. Ю., Попова И. Р., Павлов Ч. С., Ивашкин В. Т. Эффективность тримебутина малеата в лечении пациентов с функциональной диспепсией: результаты наблюдательного исследования “TREND”. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2018;28(5):67-76. doi: 10.22416/1382-4376-2018-28-5-67-76.</mixed-citation><mixed-citation xml:lang="en">Kardasheva S. S., Kartavenko I. M., Maksimova N. B., Yurieva E. Yu., Popova I. R., Pavlov C. S., Ivashkin V. T. Efficacy of Trimebutine Maleate (Trimedat®) in the Treatment of Patients with Functional Dyspepsia: Results of the “TREND” Observational Study.Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2018;28(5):67-76. (In Russ.) doi: 10.22416/1382-4376-2018-28-5-67-76.@@ Кардашева С. С., Картавенко И. М., Максимова Н. Б., Юрьева Е. Ю., Попова И. Р., Павлов Ч. С., Ивашкин В. Т. Эффективность тримебутина малеата в лечении пациентов с функциональной диспепсией: результаты наблюдательного исследования “TREND”. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2018;28(5):67-76. doi: 10.22416/1382-4376-2018-28-5-67-76.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Malfertheiner P., Megraud F., O’Morain C.A., Gisbert J. P., Kuipers E. J. et al. Management of H. pylori infection - the Maastricht V Florence Consensus Report. Gut. 2017; 66: 6-30.</mixed-citation><mixed-citation xml:lang="en">Malfertheiner P., Megraud F., O’Morain C.A., Gisbert J. P., Kuipers E. J. et al. Management of H. pylori infection - the Maastricht V Florence Consensus Report. Gut. 2017; 66: 6-30.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Solovyova G, Alianova T, Kuryk O, Taran A. Morphological peculiarities of chronic gastritis in patients with functional dyspepsia. Georgian Med News. 2019 Apr;(289):102-107. PMID: 31215888.</mixed-citation><mixed-citation xml:lang="en">Solovyova G, Alianova T, Kuryk O, Taran A. Morphological peculiarities of chronic gastritis in patients with functional dyspepsia. Georgian Med News. 2019 Apr;(289):102-107. PMID: 31215888.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Livzan M.A., Gaus O. V., Mozgovoi S. I. Chronic atrophic gastritis: patient management.Russian Medical Inquiry. 2021;5(6):427-432 (in Russ.). doi: 10.32364/2587-6821-2021-5-6-427-432.@@ Ливзан М. А., Гаус О. В., Мозговой С. И. Хронический атрофический гастрит: тактика курации пациента. РМЖ. Медицинское обозрение. 2021;5(6):427-432. doi: 10.32364/2587-6821-2021-5-6-427-432.</mixed-citation><mixed-citation xml:lang="en">Livzan M.A., Gaus O. V., Mozgovoi S. I. Chronic atrophic gastritis: patient management.Russian Medical Inquiry. 2021;5(6):427-432 (in Russ.). doi: 10.32364/2587-6821-2021-5-6-427-432.@@ Ливзан М. А., Гаус О. В., Мозговой С. И. Хронический атрофический гастрит: тактика курации пациента. РМЖ. Медицинское обозрение. 2021;5(6):427-432. doi: 10.32364/2587-6821-2021-5-6-427-432.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Koloski N, Jones M, Walker MM, et al. Population based study: atopy and autoimmune diseases are associated with functional dyspepsia and irritable bowel syndrome, independent of psychological distress. Aliment Pharmacol Ther. 2019;49(5):546-555. doi: 10.1111/apt.15120.</mixed-citation><mixed-citation xml:lang="en">Koloski N, Jones M, Walker MM, et al. Population based study: atopy and autoimmune diseases are associated with functional dyspepsia and irritable bowel syndrome, independent of psychological distress. Aliment Pharmacol Ther. 2019;49(5):546-555. doi: 10.1111/apt.15120.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Bordin D. S., Livzan M. A., Osipenko M. F., Mozgovoy S. I., Andreyev D. N., Maev I. V. The key statements of the Maastricht VI consensus. Experimental and Clinical Gastroenterology. 2022;(9):5-21. (In Russ.) doi: 10.31146/1682-8658-ecg-205-9-5-21.@@ Бордин Д. С., Ливзан М. А., Осипенко М. Ф., Мозговой С. И., Андреев Д. Н., Маев И. В. Ключевые положения консенсуса Маастрихт VI. Экспериментальная и клиническая гастроэнтерология. 2022;(9):5-21. doi: 10.31146/1682-8658-ecg-205-9-5-21.</mixed-citation><mixed-citation xml:lang="en">Bordin D. S., Livzan M. A., Osipenko M. F., Mozgovoy S. I., Andreyev D. N., Maev I. V. The key statements of the Maastricht VI consensus. Experimental and Clinical Gastroenterology. 2022;(9):5-21. (In Russ.) doi: 10.31146/1682-8658-ecg-205-9-5-21.@@ Бордин Д. С., Ливзан М. А., Осипенко М. Ф., Мозговой С. И., Андреев Д. Н., Маев И. В. Ключевые положения консенсуса Маастрихт VI. Экспериментальная и клиническая гастроэнтерология. 2022;(9):5-21. doi: 10.31146/1682-8658-ecg-205-9-5-21.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Zádori N, Németh D, Frim L, Vörhendi N, Szakó L, Váncsa S, Hegyi P, Czimmer J. Dyspepsia-Like Symptoms in Helicobacter pylori-Negative Chronic Gastritis are Associated with ASCA-, ANCA-, and Celiac Seropositivity but Not with Other Autoimmune Parameters: A Single-Centre, Retrospective Cross-Sectional Study.Int J Gen Med. 2022;15:7789-7796. doi: 10.2147/IJGM.S380419.</mixed-citation><mixed-citation xml:lang="en">Zádori N, Németh D, Frim L, Vörhendi N, Szakó L, Váncsa S, Hegyi P, Czimmer J. Dyspepsia-Like Symptoms in Helicobacter pylori-Negative Chronic Gastritis are Associated with ASCA-, ANCA-, and Celiac Seropositivity but Not with Other Autoimmune Parameters: A Single-Centre, Retrospective Cross-Sectional Study.Int J Gen Med. 2022;15:7789-7796. doi: 10.2147/IJGM.S380419.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Cardos AI, Maghiar A, Zaha DC, Pop O, Fritea L, Miere Groza F, Cavalu S. Evolution of Diagnostic Methods for Helicobacter pylori Infections: From Traditional Tests to High Technology, Advanced Sensitivity and Discrimination Tools. Diagnostics (Basel). 2022 Feb 16;12(2):508. doi: 10.3390/diagnostics12020508.</mixed-citation><mixed-citation xml:lang="en">Cardos AI, Maghiar A, Zaha DC, Pop O, Fritea L, Miere Groza F, Cavalu S. Evolution of Diagnostic Methods for Helicobacter pylori Infections: From Traditional Tests to High Technology, Advanced Sensitivity and Discrimination Tools. Diagnostics (Basel). 2022 Feb 16;12(2):508. doi: 10.3390/diagnostics12020508.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Kononov A. V. Molecular genetics and phenotype of inflammation caused by Helicobacter pylori. Omsk. scientific vestn. 2007; 3(61):17-23. (in Russ.)@@ Кононов А. В. Молекулярная генетика и фенотип воспаления, вызванного Helicobacter pylori. Омск. науч. вестн. 2007; 3 (61): 17-23.</mixed-citation><mixed-citation xml:lang="en">Kononov A. V. Molecular genetics and phenotype of inflammation caused by Helicobacter pylori. Omsk. scientific vestn. 2007; 3(61):17-23. (in Russ.)@@ Кононов А. В. Молекулярная генетика и фенотип воспаления, вызванного Helicobacter pylori. Омск. науч. вестн. 2007; 3 (61): 17-23.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Kononov A. V. Genetic regulation and phenotype of inflammation in Helicobacter pylori infection. Arch. Pat. 2009;(5):57-63. (in Russ.) EDN: KZXGNH.@@ Кононов А. В. Генетическая регуляция и фенотип воспаления при Helicobacter pylori-инфекции // Арх. пат. - 2009. - Вып. 5. - С. 57-63. EDN: KZXGNH.</mixed-citation><mixed-citation xml:lang="en">Kononov A. V. Genetic regulation and phenotype of inflammation in Helicobacter pylori infection. Arch. Pat. 2009;(5):57-63. (in Russ.) EDN: KZXGNH.@@ Кононов А. В. Генетическая регуляция и фенотип воспаления при Helicobacter pylori-инфекции // Арх. пат. - 2009. - Вып. 5. - С. 57-63. EDN: KZXGNH.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Kononov A. V., Pomorgailo E. G., Filipenko M. L. Polymorphism of IL-1β genes, its receptor antagonist and the phenotype of the inflammatory reaction of the gastric mucosa in Helicobacter pylori infection. Molecular Medicine. 2010;(1):42-45. (in Russ.) EDN: MBDDQJ.@@ Полиморфизм генов IL-1β, антагониста его рецепторов и фенотип воспалительной реакции слизистой оболочки желудка при хеликобактерной инфекции / А. В. Кононов, Е. Г. Поморгайло, М. Л. Филипенко [и др.] // Молекулярная медицина. - 2010. - № 1. - С. 42-45. - EDN MBDDQJ.</mixed-citation><mixed-citation xml:lang="en">Kononov A. V., Pomorgailo E. G., Filipenko M. L. Polymorphism of IL-1β genes, its receptor antagonist and the phenotype of the inflammatory reaction of the gastric mucosa in Helicobacter pylori infection. Molecular Medicine. 2010;(1):42-45. (in Russ.) EDN: MBDDQJ.@@ Полиморфизм генов IL-1β, антагониста его рецепторов и фенотип воспалительной реакции слизистой оболочки желудка при хеликобактерной инфекции / А. В. Кононов, Е. Г. Поморгайло, М. Л. Филипенко [и др.] // Молекулярная медицина. - 2010. - № 1. - С. 42-45. - EDN MBDDQJ.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Mozgovoy S. I., Kostenko M. B., Krolevets T. S., Livzan M. A. Autoimmune gastritis in the focus of clinician and morphologist. Farmateka. 2019;26(2):121-29. (in Russ.) doi: 10.18565/pharmateca.2019.2.121-129.@@ Мозговой С. И., Костенко М. Б., Кролевец Т. С., Ливзан М. А. Аутоиммунный гастрит в фокусе клинициста и морфолога. Фарматека. 2019;26(2):121-29. doi: 10.18565/pharmateca.2019.2.121-129.</mixed-citation><mixed-citation xml:lang="en">Mozgovoy S. I., Kostenko M. B., Krolevets T. S., Livzan M. A. Autoimmune gastritis in the focus of clinician and morphologist. Farmateka. 2019;26(2):121-29. (in Russ.) doi: 10.18565/pharmateca.2019.2.121-129.@@ Мозговой С. И., Костенко М. Б., Кролевец Т. С., Ливзан М. А. Аутоиммунный гастрит в фокусе клинициста и морфолога. Фарматека. 2019;26(2):121-29. doi: 10.18565/pharmateca.2019.2.121-129.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Stanghellini V, Chan FK, Hasler WL, et al. Gastroduodenal Disorders. Gastroenterology. 2016;150 (6):1380-1392. doi:10.1053/j.gastro.2016.02.011.</mixed-citation><mixed-citation xml:lang="en">Stanghellini V, Chan FK, Hasler WL, et al. Gastroduodenal Disorders. Gastroenterology. 2016;150 (6):1380-1392. doi:10.1053/j.gastro.2016.02.011.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
